T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAAP
1176
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $15.2M | ﹤0.01% |
503,670
+1,620
| +0.3% | +$51.5K |
|
|
PRTY
1177
DELISTED
Party City Holdco Inc.
PRTY
| $15.2M | ﹤0.01% |
1,092,794
-55,416
| -5% | -$764K |
|
|
KYNB
1178
Kyntra Bio
KYNB
$28.5M
| $15.2M | ﹤0.01% |
37,029
-24
| -0.1% | -$11K |
|
|
PTLA
1179
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $15.2M | ﹤0.01% |
643,219
+5,000
| +0.8% | +$123K |
|
1180
Deckers Outdoor
DECK
$12.7B
| $15.1M | ﹤0.01% |
1,577,286
-1,338,714
| -46% | -$12.4M |
|
1181
Arthur J. Gallagher & Co
AJG
$65B
| $15.1M | ﹤0.01% |
317,130
+258,389
| +440% | +$12M |
|
1182
Accuray
ARAY
$32.9M
| $15M | ﹤0.01% |
2,894,077
+40,870
| +1% | +$223K |
|
1183
Jazz Pharmaceuticals
JAZZ
$16B
| $14.9M | ﹤0.01% |
105,100
-2,607
| -2% | -$384K |
|
|
GWPH
1184
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $14.8M | ﹤0.01% |
+162,174
| New | +$13.7M |
|
1185
Diageo
DEO
$52.8B
| $14.8M | ﹤0.01% |
131,459
+10,700
| +9% | +$1.16M |
|
|
CLACU
1186
DELISTED
Capitol Acquisition Corp. III Unit
CLACU
| $14.8M | ﹤0.01% |
1,491,200
| – | – |
|
1187
Huron Consulting
HURN
$2.47B
| $14.8M | ﹤0.01% |
244,644
+5,500
| +2% | +$320K |
|
1188
Eldorado Gold
EGO
$10B
| $14.8M | ﹤0.01% |
656,502
-101,014
| -13% | -$2.09M |
|
|
TEN
1189
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $14.8M | ﹤0.01% |
316,640
-3,100
| -1% | -$159K |
|
|
KATE
1190
DELISTED
Kate Spade & Company
KATE
| $14.7M | ﹤0.01% |
712,463
-20,779
| -3% | -$474K |
|
1191
Pegasystems
PEGA
$5.51B
| $14.6M | ﹤0.01% |
1,085,220
+53,420
| +5% | +$704K |
|
|
STMP
1192
DELISTED
Stamps.com, Inc.
STMP
| $14.6M | ﹤0.01% |
167,090
+7,150
| +4% | +$639K |
|
|
PHX
1193
DELISTED
PHX Minerals
PHX
| $14.6M | ﹤0.01% |
876,020
+4,600
| +0.5% | +$77.2K |
|
|
BLCM
1194
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $14.6M | ﹤0.01% |
112,634
-1,510
| -1% | -$168K |
|
|
GAS
1195
DELISTED
AGL Resources Inc
GAS
| $14.6M | ﹤0.01% |
220,716
-17,400
| -7% | -$1.14M |
|
1196
ACI Worldwide
ACIW
$5.42B
| $14.4M | ﹤0.01% |
736,970
+16,660
| +2% | +$338K |
|
1197
Omnicell
OMCL
$1.72B
| $14.3M | ﹤0.01% |
419,080
+58,800
| +16% | +$1.83M |
|
|
CMA
1198
DELISTED
Comerica
CMA
| $14.3M | ﹤0.01% |
348,626
-670
| -0.2% | -$28.6K |
|
|
FL
1199
DELISTED
Foot Locker
FL
| $14.3M | ﹤0.01% |
261,080
+164,341
| +170% | +$9.53M |
|
1200
Take-Two Interactive
TTWO
$45.2B
| $14.3M | ﹤0.01% |
377,705
+144,140
| +62% | +$5.31M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.